ERVW-1 and infection: Instead, SCIV infection elicited a novel V2-directed antibody specificity that cross-neutralized a number of tier 2 HIV-1 strains with low potency by recognizing a cryptic V2 epitope in occluded-open Env trimers (27, 28).